Compounds > win 64338
Page last updated: 2024-09-04

win 64338 and bradykinin, des-arg(9)-

win 64338 has been researched along with bradykinin, des-arg(9)- in 1 studies

Compound Research Comparison

Studies
(win 64338)		Trials
(win 64338)		Recent Studies (post-2010)
(win 64338)		Studies
(bradykinin, des-arg(9)-)		Trials
(bradykinin, des-arg(9)-)		Recent Studies (post-2010) (bradykinin, des-arg(9)-)
1902300721

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schölkens, BA; Wiemer, G; Wirth, KJ1

Other Studies

1 other study(ies) available for win 64338 and bradykinin, des-arg(9)-

ArticleYear
The bradykinin B2 receptor antagonist WIN 64338 inhibits the effect of des-Arg9-bradykinin in endothelial cells.
    European journal of pharmacology, 1994, Dec-15, Volume: 288, Issue:1

    Topics: Animals; Aorta; Binding, Competitive; Bradykinin; Bradykinin Receptor Antagonists; Cattle; Cells, Cultured; Cyclic GMP; Endothelium, Vascular; Naphthalenes; Nitric Oxide; Organophosphorus Compounds; Rabbits

1994